CIM vs IRS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Chimera Investment Corporation exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating poor financial health. While the stock appears undervalued based on a Price/Book of 0.44 and a Graham Number of $34.55, these metrics are likely 'value traps' given the high Debt/Equity ratio of 5.08 and a consistent track record of earnings misses. The technical trend is completely bearish (0/100), and the high dividend yield (13.26%) is precarious given the deteriorating health scores. Overall, the valuation discount is a reflection of systemic risk rather than an opportunity.
IRS presents a classic deep-value opportunity, characterized by a Piotroski F-Score of 4/9 (Stable) and a current price ($14.52) trading at a massive discount to its Graham Number ($41.16) and Intrinsic Value ($29.89). While technical trends are currently bearish and YoY earnings growth is negative, the company maintains a very healthy balance sheet with a Debt/Equity ratio (0.51) far superior to the sector average (2.42). The most compelling catalyst is the 16.52% dividend yield, which remains sustainable given the modest 34.46% payout ratio. The significant gap between the current price and analyst targets suggests substantial upside potential if the company stabilizes its earnings volatility.
Compare Another Pair
Related Comparisons
CIM vs IRS: Head-to-Head Comparison
This page compares Chimera Investment Corporation (CIM) and IRSA Inversiones y Representaciones Sociedad Anónima (IRS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.